Asger Sand Paludan-Müller
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 16, 2025
Cost-Per-Responder Analysis for Tralokinumab and Dupilumab in Combination with Topical Corticosteroids in Patients with Moderate-To-Severe Atopic Dermatitis.Marni Wiseman, Marco Benvenuto, Liv Strømkjær
|Nov 29, 2021
Protocol: Benefits and harms of remdesivir for COVID-19 in adults: A systematic review with meta-analysis.Asger Sand Paludan-Müller, Andreas Lundh, Matthew J Page
|Aug 29, 2021
Are investigators' access to trial data and rights to publish restricted and are potential trial participants informed about this? A comparison of trial protocols and informed consent materials.Asger S Paludan-Müller, Michelle C Ogden, Mikkel Marquardsen
|May 05, 2021
Caution is advised when interpreting subgroup analyses.Klaus Munkholm, Asger Sand Paludan-Müller
|Apr 08, 2021
Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications-a methodological review.Asger S Paludan-Müller, Perrine Créquit, Isabelle Boutron
|Nov 13, 2019
Do protocols for new randomised trials take previous similar trials into account? Cohort study of contemporary trial protocols.Asger Sand Paludan-Müller, Michelle C Ogden, Mikkel Marquardsen
Pageof 2
